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ASHLEE N. BROWN 

February 4, 2005 
Ms. Tricia Knight 
Initiative Coordinator 
Office of the Attorney General 
State of California 
PO Box 994255 
Sacramento, CA 94244-25550 
Re: Request for Title and Summary for Proposed Initiative 
Dear Ms. Knight: 
Pursuant to Article 11, Section 10(d) of the California Constitution, I am submitting 
the attached proposed statewide ballot measure to your office and request that you prepare 
a title and summary of the measure as provided by law. Included with this submission is the 
required proponent affidavit signed by the proponent of this measure pursuant to section 
9608 of the California Elections Code. I have also included a check to cover the $200 filing 
fee. 
Thank you for your time and attention to this important matter. If you require 
additional information or have any questions, please feel free to contact me at (916) 442- 
7757. 
Very truly yours, 
Ashlee N. Brown 
Enclosure 
INITIATIVE MEASURE TO BE SUBMITTED DIRECTLY TO VOTERS 
SECTION 1. FINDINGS AND DECLARATION OF PURPOSE 
The People of the State of California do hereby find and declare that: 
(a) Prescription drugs are an integral part to managing acute and chronic illness 
improving quality of life; and 
(b) Prescription drugs are a convenient, cost-effective alternative to more costly medical 
interventions; and 
(c) Increasing the affordability and access of prescription medicines will significantly 
improve healthcare quality and lower overall healthcare costs. 
SECTION 2. CALIFORNIA STATE PHARMACY ASSISTANCE PROGRAM 
fCAL RX) 
Division 112 (commencing with Section130600) is added to the Health and Safety Code, 
to read as follows: 
DIVISION 112. CALIFORNIA STATE PHARMACYASSISTANCE PROGRAM (CAL 
Chapter 1. GENERAL PROVISIONS 
130600. This division shall be known, and may be cited, as the California State Pharmacy 
Assistance Program or Cal Rx. 
130601. For the purposes of this division, the following definitions shall apply: 
(a) "Benchmark price" means the price for an individual drug or aggregate price for a 
group of drugs offered by a manufacturer equal to the lowest commercial price for the 
individual drug or group of drugs. 
(b) "Cal Rx" means the California State Pharmacy Assistance Program. 
(c) "Department" means the State Department of Health Services. 
(d) "Fund" means the California State Pharmacy Assistance Program Fund. 
(e) "Inpatient" means a person who has been admitted to a hospital for observation, 
diagnosis, or treatment and who is expected to remain overnight or longer. 
(0(1) "Lowest commercial price" means the lowest purchase price for an individual 
drug, including all discounts, rebates, or free goods, available to any wholesale or retail 
commercial class of trade in California. 
(2) Lowest commercial price excludes purchases by government entities, 
purchases pursuant to Section 340B of the federal Public Health Services Act (42 
U.S.C. Sec. 256b), or nominal prices as defined in federal Medicaid drug rebate 
agreements. 
(3) A purchase price provided to an acute care hospital or acute care hospital 
pharmacy may be excluded if the prescription drug is used exclusively for an 
inpatient of the hospital. 
(4) Wholesale or retail commercial class of trade includes distributors, retail 
pharmacies, pharmacy benefit managers, health maintenance organizations, or 
any entities that directly or indirectly sell prescription drugs to consumers through 
licensed retail pharmacies, physician offices, or clinics. 
(g) "Manufacturer" means a drug manufacturer as defined in Section 4033 of the 
Business and Professions Code. 
(h) "Manufacturers rebate" means the rebate for an individual drug or aggregate rebate 
for a group of drugs necessary to make the price for the drug ingredients equal to or less 
than the applicable benchmark price. 
(i) "Prescription drug" means any drug that bears the legend: "Caution: federal law 
prohibits dispensing without prescription," "Rx only," or words of similar import. 
(j)"Private discount drug program" means a prescription drug discount card or 
manufacturer patient assistance program that provides discounted or free drugs to eligible 
individuals. For the purposes of this division, a private discount drug program is not 
considered insurance or a third-party payer program. 
(k) "Recipient7' means a resident that has completed an application and has been 
determined eligible for Cal Rx. 
(1) "Resident" means a California resident pursuant to Section 17014 of the Revenue and 
Taxation Code. 
(m) "Third-party vendor" means a public or private entity with whom the department 
contracts pursuant to subdivision (b) of Section 130602, which may include a pharmacy 
benefit administration or pharmacy benefit management company. 
130602. (a) There is hereby established the California State Pharmacy Assistance 
Program or Cal Rx. 
(b) The department shall provide oversight of Cal Rx. To implement and administer Cal 
Rx, the department may contract with a third-party vendor or utilize existing health care 
service provider enrollment and payment mechanisms, including the Medi-Cal program's 
fiscal intermediary. 
(c) Any resident may enroll in Cal Rx if determined eligible pursuant to Section 130605. 
CHAPTER 2. ELIGIBILITY AND APPLICATION PROCESS 
130605. (a) To be eligible for Cal Rx, an individual shall meet all of the following 
requirements at the time of application and reapplication for the program: 
(1) Be a resident. 
(2) Have family income, as reported pursuant to Section 130606, that does not 
exceed 300 percent of the federal poverty guidelines, as revised annually by the 
United States Department of Health and Human Services in accordance with 
Section 673(2) of the Omnibus Budget Reconciliation Act of 1981 (42 U.S.C. 
Sec. 9902), as amended. 
(3) Not have outpatient prescription drug coverage paid for in whole or in part by 
any of the following: 
(A) A third-party payer. 
(B) The Medi-Cal program. 
(C) The children's health insurance program. 
(D) The disability medical assistance program. 
(E) Another health plan or pharmacy assistance program that uses state or 
federal funds to pay part or all of the cost of the individual's outpatient 
prescription drugs. Notwithstanding any other provision of this division to 
the contrary, an individual enrolled in Medicare may participate in this 
program, to the extent allowed by federal law, for prescription drugs not 
covered by Medicare. 
(4) Not have had outpatient prescription drug coverage specified in paragraph (3) 
during any of the three months preceding the month in which the application or 
reapplication for Cal Rx is made, unless any of the following applies: 
(A) The third-party payer that paid all or part of the coverage filed for 
bankruptcy under the federal bankruptcy laws. 
(B) The individual is no longer eligible for coverage provided through a 
retirement plan subject to protection under the Employee Retirement 
Income Security Act of 1974 (29 U.S.C. Sec. 1001), as amended. 
(C) The individual is no longer eligible for the Medi-Cal program, 
children's health insurance program, or disability medical assistance 
program. 
(b) Application and an annual reapplication for Cal Rx shall be made pursuant to 
subdivision (d) of Section 130606. An applicant, or a guardian or custodian of an 
applicant, may apply or reapply on behalf of the applicant and the applicant's spouse and 
children. 
130606. (a) The department or third-party vendor shall develop an application and 
reapplication form for the determination of a resident's eligibility for Cal Rx. 
(b) The application, at a minimum, shall do all of the following: 
(1) Specify the information that an applicant or the applicant's representative 
must include in the application. 
(2) Require that the applicant, or the applicant's guardian or custodian, attest that 
the information provided in the application is accurate to the best knowledge and 
belief of the applicant or the applicant's guardian or custodian. 
(3) Include a statement printed in bold letters informing the applicant that 
knowingly making a false statement is punishable under penalty of perjury. 
(4) Specify that the application and annual reapplication fee due upon submission 
of the applicable form is fifteen dollars ($15). 
(c) In assessing the income requirement for Cal Rx eligibility, the department shall use 
the income information reported on the application and not require additional 
documentation. 
(d) Application and annual reapplication may be made at any pharmacy, physician office, 
or clinic participating in Cal Rx, through a Web site or call center staffed by trained 
operators approved by the department, or through the third-party vendor. A pharmacy, 
physician office, clinic, or third-party vendor completing the application shall keep the 
application fee as reimbursement for its processing costs. If it is determined that the 
applicant is already enrolled in Cal Rx, the fee shall be returned to the applicant and the 
applicant shall be informed of his or her current status as a recipient. 
(e) The department or third-party vendor shall utilize a secure electronic application 
process that can be used by a pharmacy, physician office, or clinic, by a Web site, by a 
call center staffed by trained operators, or through the third-party vendor to enroll 
applicants in Cal Rx. 
(f) During normal hours, the department or third-party vendor shall make a determination 
of eligibility within four hours of receipt by Cal Rx of a completed application. The 
department or third-party vendor shall mail the recipient an identification card no later 
than four days after eligibility has been determined. 
(g) For applications submitted through a pharmacy, the department or third-party vendor 
may issue a recipient identification number for eligible applicants to the pharmacy for 
immediate access to Cal Rx. 
130607. (a) The department or third-party vendor shall attempt to execute agreements 
with private discount drug programs to provide a single point of entry for eligibility 
determination and claims processing for drugs available in those private discount drug 
programs. 
(b) (1) Private discount drug programs may require an applicant to provide additional 
information, beyond that required by Cal Rx, to determine the applicant's eligibility for 
discount drug programs. 
(2) An applicant shall not be, under any circumstances, required to participate in, 
or to disclose information that would determine the applicant's eligibility to 
participate in, private discount drug programs in order to participate in Cal Rx. 
(3) Notwithstanding paragraph (2)' an applicant may voluntarily disclose or 
provide information that may be necessary to determine eligibility for 
participation in a private drug discount program. 
(c) For those drugs available pursuant to subdivision (a), the department or third-party 
vendor shall develop a system that provides a recipient with the best prescription drug 
discounts that are available to them through Cal Rx  or through private discount drug 
programs. 
(d) The recipient identification card issued pursuant to subdivision (g) of Section 130606 
shall serve as a single point of entry for drugs available pursuant to subdivision (a) and 
shall meet all legal requirements for a uniform prescription drug card pursuant to Section 
1363.03. 
CHAPTER 3. ADMINISTRATION AND SCOPE 
130615. (a) To the extent that funds are available, the department shall conduct outreach 
programs to inform residents about Cal Rx and private drug discount programs available 
through the single point of entry as specified in subdivisions (a) and (d) of Section 
130607. No outreach material shall contain the name or likeness of a drug. The name of 
the organization sponsoring the material pursuant to subdivision (b) may appear on the 
material once and in a font no larger than 10 point. 
(b) The department may accept on behalf of the state any gift, bequest, or donation of 
outreach services or materials to inform residents about Cal Rx. Neither Section 11005 of 
the Government Code, nor any other law requiring approval by a state officer of a gift, 
bequest, or donation shall apply to these gifts, bequests, or donations. For purposes of this 
section, outreach services may include, but shall not be limited to, coordinating and 
implementing outreach efforts and plans. Outreach materials may include, but shall not 
be limited to, brochures, pamphlets, fliers, posters, advertisements, and other promotional 
items. 
(c) An advertisement provided as a gift, bequest, or donation pursuant to this section shall 
be exempt from Article 5 (commencing with Section 11080) of Chapter 1 of Part 1 of 
Division 3 of Title 2 of the Government Code. 
130616. (a) Any pharmacy licensed pursuant to Article 7 (commencing with Section 
41 10) of Chapter 9 of Division 2 of the Business and Professions Code may participate in 
Cal Rx. 
(b) Any manufacturer, as defined in subdivision (g) of Section 130601, may participate in 
Cal Rx. 
130617. (a) This division shall apply only to prescription drugs dispensed to noninpatient 
recipients. 
(b) The amount a recipient pays for a drug within Cal Rx shall be equal to the pharmacy 
contract rate pursuant to subdivision (c), plus a dispensing fee that shall be negotiated as 
part of the rate pursuant to subdivision (c), less the applicable manufacturers rebate. 
(c) The department or third-party vendor may contract with participating pharmacies for 
a rate other than the pharmacist's usual and customary rate. However, the department 
must approve the contracted rate of a third-party vendor. 
(d) The department or third-party vendor shall provide a claims processing system that 
complies with all of the following requirements: 
(1) Charges a price that meets the requirements of subdivision (b). 
(2) Provides the pharmacy with the dollar amount of the discount to be returned to 
the pharmacy. 
(3) Provides a single point of entry for access to private discount drug programs 
pursuant to Section 130607. 
(4) Provides drug utilization review warnings to pharmacies consistent with the 
drug utilization review standards outlined in Section 1927 of the federal Social 
Security Act (42 U.S.C. Sec. 1396r-8(g)). 
(e) The department or third-party vendor shall pay a participating pharmacy the discount 
provided to recipients pursuant to subdivision (b) by a date that is not later than two 
weeks after the claim is received. 
(f) The department or third-party vendor shall develop a program to prevent the 
occurrence of fraud in Cal Rx. 
(g) The department or third-party vendor shall develop a mechanism for recipients to 
report problems or complaints regarding Cal Rx. 
13061 8. (a) In order to secure the discount required pursuant to subdivisions (b) and (c) 
of Section 130617, the department or third-party vendor shall attempt to negotiate drug 
rebate agreements for Cal Rx with drug manufacturers. 
(b) Each drug rebate agreement shall do all of the following: 
( I )  Specify which of the manufacturer's drugs are included in the agreement. 
(2) Permit the department to remove a drug from the agreement in the event of a 
dispute over the drug's utilization. 
(3) Require the manufacturer to make a rebate payment to the department for each 
drug specified under paragraph (1) dispensed to a recipient. 
(4) Require the rebate payment for a drug to be equal to the amount determined 
by multiplying the applicable per unit rebate by the number of units dispensed. 
(5) Define a unit, for purposes of the agreement, in compliance with the standards 
set by the National Council of Prescription Drug Programs. 
(6) Require the manufacturer to make the rebate payments to the department on at 
least a quarterly basis. 
(7) Require the manufacturer to provide, upon the request of the department, 
documentation to validate that the per unit rebate provided complies with 
paragraph (4). 
(8) Permit a manufacturer to audit claims for the drugs the manufacturer provides 
under Cal Rx. Claims information provided to manufacturers shall comply with 
all federal and state privacy laws that protect a recipient's health information. 
(c) To obtain the most favorable discounts, the department may limit the number of drugs 
available within Cal Rx. 
(d) The entire amount of the drug rebates negotiated pursuant to this section shall go to 
reducing the cost to Cal Rx recipients of purchasing drugs. The Legislature shall annually 
appropriate an amount to cover the state's share of the discount provided by this section. 
(e) The department or third-party vendor may collect prospective rebates from 
manufacturers for payment to pharmacies. The amount of the prospective rebate shall be 
contained in drug rebate agreements executed pursuant to this section. 
( f )  Drug rebate contracts negotiated by the third-party vendor shall be subject to review 
by the department. The department may cancel a contract that it finds not in the best 
interests of the state or Cal Rx recipients. 
(g) The third-party vendor may directly collect rebates from manufacturers in order to 
facilitate the payment to pharmacies pursuant to subdivision (e) of Section 13061 7. The 
department shall develop a system to prevent diversion of funds collected by the third- 
party vendor. 
130619. (a) The department or third-party vendor shall generate a monthly report that, at 
a minimum, provides all of the following: 
( I )  Drug utilization information. 
(2) Amounts paid to pharmacies. 
(3) Amounts of rebates collected fi-om manufacturers. 
(4) A Summary of the problems or complaints reported regarding Cal Rx. 
(b) Information provided in paragraphs (I), (2), and (3) of subdivision (a) shall be at the 
national drug code level. 
130620. (a) The department or third-party vendor shall deposit all payments received 
pursuant to Section 13061 8 into the California State Pharmacy Assistance Program Fund, 
which is hereby established in the State Treasury. 
(b) Notwithstanding Section 13340 of the Government Code, moneys in the fund are 
hereby appropriated to the department without regard to fiscal years for the purpose of 
providing payment to participating pharmacies pursuant to Section 1306 17 and for 
defraying the costs of administering Cal Rx. Notwithstanding any other provision of law, 
no money in the fund is available for expenditure for any other purpose or for loaning or 
transferring to any other fund, including the General Fund. 
13062 1. The department may hire any staff needed for the implementation and oversight 
of Cal Rx. 
130622. The department shall seek and obtain confirmation from the federal Centers for 
Medicare and Medicaid Services that Cal Rx complies with the requirements for a state 
pharmaceutical assistance program pursuant to Section 1927 of the federal Social 
Security Act (42 U.S.C. Sec. 1396r-8) and that discounts provided under the program are 
exempt from Medicaid best price requirements. 
130623. (a) Contracts and change orders entered into pursuant to this division and any 
project or systems development notice shall be exempt from all of the following: 
(1) The competitive bidding requirements of State Administrative Manual 
Management Memo 03-1 0. 
(2) Part 2 (commencing with Section 10 100) of Division 2 of the Public Contract 
Code. 
(3) Article 4 (commencing with Section 191 30) of Chapter 5 of Part 2 of Division 
5 of the Government Code. 
(b) Change orders entered into pursuant to this division shall not require a contract 
amendment. 
130624. The department may terminate Cal Rx if the department makes any one of the 
following determinations: 
(a) That there are insufficient discounts to participants to make Cal Rx viable. 
(b) That there are an insufficient number of applicants for Cal Rx. 
(c) That the department is unable to find a responsible third-party vendor to administer 
Cal Rx. 
130625. Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of 
Division 3 of Title 2 of the Government Code, the director may implement this division 
in whole or in part, by means of a provider bulletin or other similar instructions, without 
taking regulatory action. 
SECTION 3: GENERAL PROVISIONS 
(a) Conflicting Measures. 
(1) This measure is intended to be comprehensive. It is the intent of the People 
that in the event that this measure and another initiative measure or measures 
relating to the same subject shall appear on the same statewide election ballot, the 
provisions of the other measure or measures shall be deemed to be in conflict with 
this measure. In the event that this measure shall receive a greater number of 
affirmative votes, the provisions of this measure shall prevail in their entirety, and 
all provisions of the other measure or measures shall be null and void. 
(2) If this measure is approved by voters but superseded by law by any other 
conflicting ballot measure approved by the voters at the same election, and the 
conflicting ballot measure is later held invalid, this measure shall be self- 
executing and given full force of law. 
(b) Severability: The provisions of this chapter are severable. If any provision of this 
chapter or its application is held invalid, that invalidity shall not affect other provisions or 
applications that can be given effect without the invalid provision or application. 
(c) Amendment: The provisions of this Act may be amended by a statute that is passed by 
a vote of two-thirds of the membership of each house of the Legislature and signed by the 
Governor. All amendments to this Act shall be to further the Act and shall be consistent 
with its purposes. 
